Patel Sudi, Tutchenko Larysa
"Svjetlost" Speciality Eye Hospital, School of Medicine, University of Rijeka, Zagreb, Croatia.
Kyiv City Clinical Ophthalmological Hospital "Eye Microsurgical Center", Kyiv, Ukraine.
Clin Ophthalmol. 2021 Jul 26;15:3157-3164. doi: 10.2147/OPTH.S284616. eCollection 2021.
Recent evidence indicates that the corneal back surface astigmatism (CBSA) contributes to the refractive state of the eye in cataract surgery, especially with the implantation of toric intraocular lenses. But this has been met with some scepticism. A review of key studies performed over the past three decades shows that the mean CBSA power ranges from 0.18(±0.16)D to 1.04(±0.20)D. The clinical assessment of CBSA is problematic. There is poor agreement between the current automated systems for assessment of CBSA and it is assumed that these systems directly measure the CBSA. But CBSA cannot be measured directly in vivo. A historical review of methods used to quantify the curvature of the posterior corneal surface reveals that CBSA estimated by current systems is based on values for corneal front surface astigmatism, corneal refractive index, central corneal thickness, corneal thickness at peripheral locations and the exact distance between the corneal apex and each one of these peripheral locations. Doubts and errors in these values, coupled with the precise details of the algorithm incorporated to estimate CBSA, are the likely sources of the lack of agreement between current systems. These systematic errors cloud the assessment of CBSA. Mean CBSA may be low, but it varies from case to case. There is a clear need for a realistic, practical procedure for clinicians to independently calibrate systems for estimating CBSA. This would help to reduce uncertainty and the discrepancies between instruments designed to measure the same parameter.
近期证据表明,角膜后表面散光(CBSA)在白内障手术中对眼睛的屈光状态有影响,尤其是在植入散光人工晶状体时。但这一观点受到了一些质疑。对过去三十年进行的关键研究的回顾表明,CBSA的平均度数范围为0.18(±0.16)D至1.04(±0.20)D。CBSA的临床评估存在问题。目前用于评估CBSA的自动化系统之间的一致性较差,并且假定这些系统直接测量CBSA。但CBSA无法在体内直接测量。对用于量化角膜后表面曲率的方法的历史回顾表明,当前系统估计的CBSA是基于角膜前表面散光、角膜折射率、中央角膜厚度、周边位置的角膜厚度以及角膜顶点与每个周边位置之间的确切距离的值。这些值中的疑问和误差,再加上用于估计CBSA的算法的精确细节,可能是当前系统之间缺乏一致性的原因。这些系统误差模糊了CBSA的评估。CBSA的平均值可能较低,但因病例而异。显然需要一种切实可行的程序,让临床医生能够独立校准用于估计CBSA的系统。这将有助于减少不确定性以及旨在测量同一参数的仪器之间的差异。